External Links and News
Here you can find links to sites and news reports relevant to blood cancer trials in the UK
MyeCare Registry to improve standards of care and outcomes for Acute Myeloid Leukaemia (AML) patients
A collaboration between haematology specialists, Accelerating Clinical Trials Ltd (ACT) and Dendrite Clinical Systems, has…
Let’s talk Blood Cancer Podcast
If you do one thing today then please listen to the following podcast.
Elisabeth Kueenburg
"I want to thank the whole ACT and IMPACT network for your great collaboration throughout…
A Night To Remember In The History Of ACT
The evening of the 1st of October marked a special occasion in the history of…
ACT to Attend ASH 2024: Advancing Blood Cancer Research Together
ACT to Attend ASH 2024: Advancing Blood Cancer Research Together
Accelerating Clinical Trials Ltd Appoints New CEO
Accelerating Clinical Trials Ltd Appoints New CEO
ACT welcomes financial support from Anthony Nolan
With support from Cure Leukaemia and NHSBT, ACT has been established as a commercial clinical…
Dr Kate Cwynarski
"There has never been a greater need for clinical trials of new therapies in lymphoma…
Prof Graham Jackson
“ACT’s innovative structure and ability to accelerate the delivery of practice informing trials in conjunction…
Prof Paresh Vyas
"At a time of rapid therapeutic innovation in blood cancers, new trial delivery models such…
Lord O’Shaughnessy’s landmark report
We welcome Lord O’Shaughnessy’s landmark report highlighting the importance of developing innovative models if the…
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.